Research Use Only·Third-Party Analytical Testing·COA Available·Authorized Researchers OnlyResearch Use Only · COA Available · Authorized Researchers
peptide-solutions
GLP-1 receptor agonist for metabolic research
Research Compound
Manufactured under strict quality control protocols with full analytical testing. Certificate of Analysis (COA) available upon request.
Semaglutide is a GLP-1 receptor agonist approved for type 2 diabetes and chronic weight management. Research continues to explore cardiovascular, renal, and neurological benefits.
Compound Specifications
Select the amount contained in each vial.
Choose one vial, or choose a kit with 10 units priced as 8.
Amount per vial: 5mg
Scientific Documentation
Detailed research information, pharmacological profile, and handling specifications
GLP-1R agonism stimulates glucose-dependent insulin secretion, suppresses glucagon, slows gastric emptying, and activates hypothalamic satiety centers. C-18 fatty acid modification enables albumin binding.
Verified Buyer Reviews
Loading reviews...
This product is intended strictly for laboratory and research purposes only. Not for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease. By purchasing, you confirm that you are an authorized researcher or institution and that this product will be used solely for legitimate research purposes in compliance with all applicable laws and regulations.
Other research peptides you may be interested in
Dual GLP-1/GIP receptor agonist for metabolic research
from $109
Triple-action GLP-1/GIP/Glucagon receptor agonist
from $125
GHRH analog for metabolic and body composition research
from $70
